{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-0779-0023", "FDA", "FDA-2014-D-0779", "Current Good Manufacturing Practice\u2014Guidance for Human Drug\nCompounding Outsourcing Facilities Under Section 503B of the FD&C Act; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2018-12-11T05:00:00Z", 2018, 12, "2018-12-11T05:00:00Z", "2019-02-12T04:59:59Z", "2019-08-20T19:41:28Z", "2018-26724", 0, 0, "0900006483980a94"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-0779-0023"], "units": {}, "query_ms": 0.3652700688689947, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}